These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30675707)

  • 41. Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction.
    Dorsey P; Keel C; Klavens M; Hellstrom WJ
    Expert Opin Pharmacother; 2010 May; 11(7):1109-22. PubMed ID: 20402554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Importance of patient's choice in the treatment of erectile dysfunction].
    Corman A; Chevret-Méasson M; Gehchan N
    Presse Med; 2012 Jun; 41(6 Pt 1):593-7. PubMed ID: 22377459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of Melanoma With Phosphodiesterase Type 5 Inhibitor Use Among Patients With Erectile Dysfunction, Pulmonary Hypertension, and Lower Urinary Tract Symptoms.
    Shkolyar E; Li S; Tang J; Eisenberg ML
    J Sex Med; 2018 Jul; 15(7):982-989. PubMed ID: 29884444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple PDE5Is use as a marker of decreased overall men's health: A real-life study.
    Oreggia D; Ventimiglia E; Capogrosso P; Boeri L; Cazzaniga W; Pederzoli F; Chierigo F; Dehò F; Montorsi F; Salonia A
    PLoS One; 2018; 13(8):e0201601. PubMed ID: 30096166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
    Ortaç M; Çayan S; Çalişkan MK; Yaman MÖ; Okutucu TM; Semerci MB; Altay AB; Balbay MD; Özcan MF; Kadioğlu A
    Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
    Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction.
    Axilrod AC
    Curr Med Res Opin; 2007 Dec; 23(12):3189-98. PubMed ID: 17991309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Continuous use of PDE5 inhibitors in the treatment of erectile dysfunction: New insights and opportunities].
    Puigvert AM; Prieto R; García F
    Rev Int Androl; 2018; 16(1):28-33. PubMed ID: 30063020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails.
    Lee M; Sharifi R
    Drugs Aging; 2018 Mar; 35(3):175-187. PubMed ID: 29464656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study of the prevalence and patterns of phosphodiesterase type 5 inhibitor use among sexually active Egyptian males: A National Cross-sectional Survey.
    Attia AA; Abdel-Hameed AKS; Amer MAEM; Mamdouh H; GamalEl Din SF; El-Moslemany HEGM
    Andrologia; 2019 Oct; 51(9):e13364. PubMed ID: 31304987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vardenafil improves penile erection in type 2 diabetes mellitus patients with erectile dysfunction: role of tropomyosin.
    Zamorano-León JJ; Olivier C; de Las Heras N; Mateos-Cáceres PJ; Brime Menéndez R; Rodríguez-Sierra P; Martín Palacios N; Manso LS; Modrego J; Segura A; Macaya C; López-Farré AJ
    J Sex Med; 2013 Dec; 10(12):3110-20. PubMed ID: 24112450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cardiovascular diseases and erectile dysfunction].
    Pomeshkina SA; Pomeshkin EV; Barbarash OL; Neĭmark AI
    Ter Arkh; 2010; 82(10):37-40. PubMed ID: 21341462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Erectile dysfunction as the first sign of systemic vascular diseases and of organovascular arterial ischemic diseases. Guidelines and Challenge of the Angiology section of Slovak Medical Chamber (AS SMC, 2015)].
    Gavorník P; Dukát A; Gašpar Ľ; Medová D; Faktorová X; Gavorníková E
    Vnitr Lek; 2015; 61(7-8):660-9. PubMed ID: 26375693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PDE5 inhibitor treatment persistence and adherence in Brazilian men: post-hoc analyses from a 6-month, prospective, observational study.
    Cairoli C; Reyes LA; Henneges C; Sorsaburu S
    Int Braz J Urol; 2014; 40(3):390-9. PubMed ID: 25010306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erectile dysfunction and cardiovascular disease.
    Menezes A; Artham S; Lavie CJ; Milani RV; O'Keefe J
    Postgrad Med; 2011 May; 123(3):7-16. PubMed ID: 21566411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BPH/LUTS and ED: common pharmacological pathways for a common treatment.
    Fusco F; D'Anzeo G; Sessa A; Pace G; Rossi A; Capece M; d'Emmanuele di Villa Bianca R
    J Sex Med; 2013 Oct; 10(10):2382-93. PubMed ID: 23875757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Avanafil - a further step to tailoring patient needs and expectations.
    Boeri L; Capogrosso P; Ventimiglia E; Serino A; La Croce G; Russo A; Damiano R; Montorsi F; Salonia A
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1171-81. PubMed ID: 27232892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of phosphodiesterase-5 inhibitors for treating erectile dysfunction in kidney transplant recipients: a meta-analysis.
    Fanbin L; Mei Y; Yan Z; Yirong Y; Shaoling Z; Yong C; Peng X
    Exp Clin Transplant; 2014 Jun; 12(3):184-9. PubMed ID: 24907716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis.
    Limoncin E; Gravina GL; Corona G; Maggi M; Ciocca G; Lenzi A; Jannini EA
    Andrology; 2017 Sep; 5(5):863-872. PubMed ID: 28787547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 2018 Revision to the Process of Care Model for Management of Erectile Dysfunction.
    Mulhall JP; Giraldi A; Hackett G; Hellstrom WJG; Jannini EA; Rubio-Aurioles E; Trost L; Hassan TA
    J Sex Med; 2018 Oct; 15(10):1434-1445. PubMed ID: 30057278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.